The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact.

作者: Mario Maggi , Claude Schulman , Richard Quinton , Sue Langham , Kerstin Uhl-Hochgraeber

DOI: 10.1111/J.1743-6109.2007.00531.X

关键词:

摘要: ABSTRACT Introduction Testosterone deficiency syndrome (TDS) causes a wide range of symptoms that can lead to significant morbidity. Preliminary evidence has also linked TDS with premature mortality and number comorbid diseases including diabetes metabolic syndrome. Such associations substantial economic quality- of-life implications, the magnitude which remains largely unknown. Aim To review quality-of-life consequences untreated condition consider likely health benefits testosterone treatment. Methods A systematic four main areas: epidemiological TDS, estimates cost illness, impact on quality-of-life, cost-effectiveness Main Outcome Measure Review peer-reviewed literature. Results The lack clear universally accepted diagnostic criteria uncertainty surrounding link between some its complicate estimation burden illness TDS. Consequences potentially increased include depression, sexual dysfunction, mild cognitive impairment, osteoporosis, cardiovascular disease, mortality. However, although good exists demonstrating an association dysfunction is less strong for incidence fractures mortality, highly controversial disease. are patients' quality life function, energy levels, body composition, mood, function. Conclusion Understanding only first step decision makers need take decide whether allocate scarce resources treat condition. make informed decisions when who information needed available treatments. data would highlight treatment physicians, patients, society as whole. Maggi M, Schulman C, Quinton R, Langham S, Uhl-Hochgraeber K. in adult men: Economic impact.

参考文章(93)
M. Linet, J. G. Gurney, L. A. G. Ries, M. A. Smith, T. Tamra, G. R. Bunin, J. L. Young, Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995.. ,(1999)
Clas Rehnberg, Jules Angst, Bengt Jönsson, Patrik Sobocki, Cost of depression in Europe. Journal of Mental Health Policy and Economics. ,vol. 9, pp. 87- 98 ,(2006)
Atlee R. Johnson, Jonathan P. Jarow, Is Routine Endocrine Testing of Impotent Men Necessary? Journal of Urology. ,vol. 147, pp. 1542- 1543 ,(1992) , 10.1016/S0022-5347(17)37620-6
Stephen Lazarou, Luis Reyes‐Vallejo, Abraham Morgentaler, ORIGINAL RESEARCH—ENDOCRINOLOGY: Wide Variability in Laboratory Reference Values for Serum Testosterone The Journal of Sexual Medicine. ,vol. 3, pp. 1085- 1089 ,(2006) , 10.1111/J.1743-6109.2006.00334.X
Akinlolu Ojumu, Adrian S. Dobs, Is hypogonadism a risk factor for sexual dysfunction Journal of Andrology. ,vol. 24, ,(2003) , 10.1002/J.1939-4640.2003.TB02746.X
Davidson Jm, Banks Sm, Burris As, Sherins Rj, Carter Cs, A Long‐term, Prospective Study of the Physiologic and Behavioral Effects of Hormone Replacement in Untreated Hypogonadal Men Journal of Andrology. ,vol. 13, pp. 297- 304 ,(1992) , 10.1002/J.1939-4640.1992.TB00319.X
Guy G. T'Sjoen, Sara De Vos, Stefan Goemaere, Inge Van Pottelbergh, Michel Dierick, Cees Van Heeringen, Jean-Marc Kaufman, Sex Steroid Level, Androgen Receptor Polymorphism, and Depressive Symptoms in Healthy Elderly Men Journal of the American Geriatrics Society. ,vol. 53, pp. 636- 642 ,(2005) , 10.1111/J.1532-5415.2005.53212.X
T. MULLIGAN, M. F. FRICK, Q. C. ZURAW, A. STEMHAGEN, C. MCWHIRTER, Prevalence of hypogonadism in males aged at least 45 years: the HIM study International Journal of Clinical Practice. ,vol. 60, pp. 762- 769 ,(2008) , 10.1111/J.1742-1241.2006.00992.X
Linus Jönsson, Maria Eriksdotter Jönhagen, Lena Kilander, Hilkka Soininen, Merja Hallikainen, Gunhild Waldemar, Harald Nygaard, Niels Andreasen, Bengt Winblad, Anders Wimo, Determinants of costs of care for patients with Alzheimer's disease. International Journal of Geriatric Psychiatry. ,vol. 21, pp. 449- 459 ,(2006) , 10.1002/GPS.1489